Skip to content
ppharmaranks
Menu

fingolimod

Fingolimod is a sphingosine 1-phosphate receptor modulator used to treat Relapsing-Remitting Multiple Sclerosis.

Sphingosine 1-Phosphate Receptor Modulator · by Standard Chem and Pharm Co Ltd

Not yet rated· sourced from the FDA label
Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Pharmacy acquisition cost fell 15% — $4.2008 → $3.5631 per ea (CMS NADAC)source

Verified againstopenFDANIH DailyMedRxClass

Key facts

Active ingredient
Fingolimod
Form
Capsule
Strength
Fingolimod EQ 0.5MG Base
Type
Prescription (Rx)
Brand or generic
Generic
Half-life
about 6 to 9 days (average apparent terminal half-life) (how long it stays in your system)
What the pharmacy pays
~$106.89 for 30 — not your price
FDA application
ANDA207940
Availability
Discontinued (per FDA)

Storing Fingolimod, and how long it keeps

Quoted from this product’s own FDA label. Storage belongs to the product and its device, not to the drug in general — a pen and a tablet of the same medicine are kept completely differently.

  • “Fingolimod capsules should be stored at 20°C to 25°C (68°F to 77°F); excursions permitted to 15ºC to 30ºC (59ºF to 86ºF).”
  • “Fingolimod capsules should be stored at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature].”
  • “Fingolimod capsules should be stored at 25ºC (77ºF); excursions permitted to 15º to 30ºC (59º to 86ºF) [See USP Controlled Room Temperature].”
  • “Fingolimod capsules should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].”

How long does Fingolimod stay in your body?

The elimination half-life of fingolimod is about 6 to 9 days (average apparent terminal half-life) — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. This is the terminal (elimination) half-life, not a distribution phase. Fingolimod is a prodrug-like parent: it is phosphorylated by sphingosine kinase to fingolimod-phosphate, the pharmacologically active moiety. The label says fingolimod-phosphate blood levels decline in parallel with the parent in the terminal phase, "yielding similar half-lives for both" — so the active form does not outlast the parent, but it also does not clear any faster. Because the half-life is measured in days, blood levels take 1 to 2 months of once-daily dosing to reach steady state, and lymphocyte counts typically take 1 to 2 months to return to normal after stopping. Liver impairment: the apparent elimination half-life is unchanged in mild hepatic impairment but is prolonged by about 50% in moderate or severe impairment (Child-Pugh B or C); fingolimod AUC rises 12%/44%/103% in mild/moderate/severe. Kidney impairment: in severe renal impairment there is NO change in apparent elimination half-life (though fingolimod Cmax/AUC rise 32%/43%, and two inactive metabolites, M2 and M3, accumulate 3- and 13-fold). Older adults: the label states no dose adjustment is expected based on the elimination mechanism and population PK, but does not report a separate half-life for this group and notes experience above age 65 is limited. Not a drug-test detection window and not dosing guidance.

This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: DailyMed — FINGOLIMOD (fingolimod hydrochloride) capsule, §12.3 Pharmacokinetics.

Drug class

How this class works, per Fingolimod - StatPearls - NCBI Bookshelf.

May treat (source: NIH RxClass)

See how Fingolimod ranks — best-rated sphingosine 1-phosphate receptor modulator for:

Dosage forms

Capsule

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Fingolimod treat?
Fingolimod (Fingolimod) may be used to treat relapsing-remitting multiple sclerosis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
How does Fingolimod work?
Fingolimod is a sphingosine 1-phosphate receptor modulator. These drugs mimic the natural lipid signal S1P and bind its receptors on immune cells called lymphocytes. This traps the lymphocytes inside the lymph nodes so fewer circulate in the blood, reducing the inflammatory attack on the nervous system or gut in diseases like multiple sclerosis.
How much does Fingolimod cost?
Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $106.89 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
Is there a coupon or discount for Fingolimod?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Fingolimod. To pay less, Fingolimod is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Fingolimod?
Fingolimod is marketed by Standard Chem and Pharm Co Ltd. You can see Standard Chem and Pharm Co Ltd's full profile, rating, and other products on pharmaranks.
Is Fingolimod a brand-name or generic drug?
Fingolimod is a generic medication; its active ingredient is Fingolimod. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
Is Fingolimod available over the counter?
No. Fingolimod is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Fingolimod come in?
Fingolimod is currently marketed as capsule, per the FDA's National Drug Code Directory.
What class of drug is Fingolimod?
Fingolimod is classified as sphingosine 1-phosphate receptor modulator, per the FDA's Established Pharmacologic Class.
Is Fingolimod FDA-registered?
Fingolimod is on record with the U.S. FDA under application number ANDA207940. You can verify this on its official FDA label.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about Fingolimod

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 6,533 reports naming Fingolimod, and the FDA flagged 74% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • multiple sclerosis relapse661 reports
  • fatigue527 reports
  • lymphopenia485 reports
  • multiple sclerosis348 reports
  • headache311 reports
  • dizziness249 reports
  • lymphocyte count decreased221 reports
  • hypoaesthesia218 reports

Read these as a signal, not a rate. A report does not mean Fingolimod caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Fingolimod head-to-head

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.